title: Designing an extended release waxy matrix tablet containing nicardipine-hydroxy propyl β cyclodextrin complex.
abstract: OBJECTIVE
  The current study aimed to prepare a sustained release tablet for a drug which has poor solubility in alkaline medium using complexation with cyclodextrin. Nicardipine hydrochloride (NC) a weak basic drug was chosen as a model drug for this study.
  
  
  METHODS
  Firstly the most suitable binary system NC-HPβCD was selected in order to improve drug solubility in the intestinal media and then embedding the complexed drug into a plastic matrix, by fusion method, consists of glycerol monostearate (GMS) as an inert waxy substance and polyethylene glycol 4000 (PEG4000) as a channeling agent, after that the final solid dispersion [(NC:HPβCD):GMS:PEG4000] which was prepared at different ratios was mixed with other excipients, avicel PH101, lactose, and talc, to get a tablet owning dissolution profile complying with the FDA and USP requirements for the extended release solid dosage forms.
  
  
  RESULTS
  Infrared spectroscopy (IR), differential scanning colorimetry (DSC), polarized microscopy and X-ray diffractometry proved that the coevaporation technique was effective in preparing amorphous cyclodextrin complexes with NC and trapping of NC within the HPβCD cavity by dissolving both in ethanol and evaporate the solvent using a rotavapor at 65 °C. Dissolution profile of NC enhanced significantly in pH 6.8 from NC:HPβCD inclusion complex prepared by the rotavapor (t-test Student p < 0.05). The release of NC from tablet containing [(NC:HPβCD):GMS:PEG4000] [(1):0.75:0.5] (w/w/w) solid dispersion (F8) was complying with the FDA dissolution requirements for extended release dosage forms, and studying the kinetics of the release showed that the diffusional contribution is the major factor controlling the drug release from that formula.
  
  
  CONCLUSIONS
  The prepared waxy matrix tablet containing NC complexes with CD shows promising results as extended release tablets.
authors: Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Damascus University, Syria.
authors: Hind
authors: H
authors: Al-Zein
authors: Khalil
authors: K
authors: Sakeer
authors: Fars K
authors: FK
authors: Alanazi
keywords: Glycerol monostearate; Hydrophilic cyclodextrin derivative; Nicardipine; Plastic matrix; Solid dispersion
references: Eur J Pharm Sci. 1998 Jul;6(3):241-6
references: 9795073
references: Drug Dev Ind Pharm. 1998 Jun;24(6):573-6
references: 9876626
references: J Pharm Biomed Anal. 2004 Apr 16;35(2):267-75
references: 15063461
references: Pharm Res. 2004 Feb;21(2):201-30
references: 15032302
references: Br J Clin Pharmacol. 1985;20 Suppl 1:23S-28S
references: 4027149
references: Xenobiotica. 1980 Dec;10(12):897-903
references: 7210702
references: Farmaco. 2004 Feb;59(2):155-61
references: 14871508
references: Pharmazie. 2003 Jan;58(1):38-43
references: 12622251
references: Int J Pharm. 2004 Mar 1;271(1-2):53-62
references: 15129973
references: Clin Pharmacokinet. 1988 Jul;15(1):1-14
references: 3042243
references: J Pharm Sci. 1978 Mar;67(3):357-60
references: 641723
references: Drugs. 1987 Apr;33(4):296-345
references: 3297616
references: Eur J Pharm Biopharm. 2007 May;66(2):210-9
references: 17196805
references: Eur J Pharm Sci. 2002 Feb;15(1):79-88
references: 11803134
references: Chem Pharm Bull (Tokyo). 1977 Dec;25(12):3340-6
references: 608225